Plain-English translation of NCT07428967 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different approaches to treating atrial fibrillation (a condition where the heart's upper chambers beat irregularly). All participants will receive a procedure called AV node ablation to help control their heart rhythm, and then will be randomly assigned to receive one of two types of pacemakers: one that paces from the right side of the heart, or one that paces from a different area on the left side. The study wants to see which pacemaker approach helps keep the heart working better over time.
Some people with atrial fibrillation need a pacemaker after ablation treatment, but traditional right-side pacing can sometimes weaken the heart muscle over time. This trial is testing whether a newer left-side pacing approach can prevent that weakening and help patients feel better and stay more active.
You likely qualify if…
You likely don't qualify if…
You would undergo the planned AV node ablation procedure, then be randomly assigned to receive either a traditional right-side pacemaker or a newer left-side pacemaker. After that, you would have follow-up visits where doctors check how your heart is functioning, measure your heart's pumping ability, and assess how you're feeling and your ability to exercise. The study will track your progress over time to compare which pacemaker type works better at keeping your heart strong.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Germany